Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.
Philip Morris International (PM) maintains a dynamic presence in global markets through strategic initiatives and product evolution. This news hub provides investors and industry observers with essential updates about the company's financial performance, reduced-risk product developments, and regulatory engagements.
Access timely press releases and curated analysis covering PM's quarterly earnings, market expansion strategies, and innovations in smoke-free alternatives like heatsticks and oral nicotine products. Our repository simplifies tracking of critical milestones including acquisition announcements, sustainability efforts, and leadership changes impacting this tobacco industry leader.
All content undergoes rigorous verification to ensure accuracy and relevance for stakeholders monitoring PM's transition toward reduced-risk portfolios. Bookmark this page for streamlined access to operational updates and strategic disclosures from one of the world's largest publicly traded tobacco enterprises.
Philip Morris International (PM) released a survey revealing that misinformation about smoke-free products hinders progress towards a smoke-free future. Conducted by Povaddo across 26 countries, the survey indicates that 79% of respondents believe adult smokers should have accurate information about smoke-free alternatives. Despite this demand, nearly 50% of adults incorrectly perceive e-cigarettes as equally harmful as traditional cigarettes. The findings highlight the need for better education on smoke-free options, as 91% of smokers who switched cited accurate information as crucial in their decision.
Philip Morris International CEO Jacek Olczak spoke at the 2021 Concordia Annual Summit, emphasizing the lessons learned from COVID-19 and advocating for innovative partnerships to tackle global issues. He highlighted the challenge of transitioning from traditional tobacco products to scientifically-backed smoke-free alternatives, underscoring the resistance from certain anti-tobacco groups. Olczak noted the significant potential for harm reduction, particularly citing the decline in cigarette use in Japan due to heated tobacco products. PMI aims to transform the tobacco industry, targeting a smoke-free future.
PMI has successfully acquired 74.77% of Vectura shares, surpassing the required 50% threshold for an unconditional offer. This acquisition, part of PMI's strategy to advance its Beyond Nicotine ambitions, aims to generate at least $1 billion from new product lines by 2025. The partnership will enhance Vectura’s development in inhaled therapeutics, leveraging PMI’s substantial investments of $8.1 billion since 2008 in smoke-free innovations. With its extensive pipeline of inhaled products, Vectura is set to play a pivotal role in PMI's transformation into adjacent health sectors.
Philip Morris International (PM) has completed its acquisition of Fertin Pharma for DKK 5.1 billion (approximately USD 820 million). This strategic move aims to enhance PM's portfolio of smoke-free products and expand into self-care wellness markets. Fertin Pharma, with its 850+ employees and expertise in oral delivery systems, is expected to significantly contribute to PM's 2025 objectives of generating over 50% of revenues from smoke-free products. The acquisition's impact on PM's full-year 2021 adjusted EPS is expected to be immaterial.
The Board of Directors of Philip Morris International (NYSE: PM) has increased the quarterly dividend by 4.2% to an annualized rate of
Philip Morris International (NYSE: PM) has reaffirmed its 2021 full-year diluted EPS forecast, expecting a range between
Philip Morris International (NYSE: PM) will conduct a live video webcast featuring Chief Financial Officer Emmanuel Babeau during the Barclays Global Consumer Staples Conference on September 8, 2021, at 8:00 a.m. ET. The event will be conducted virtually, and attendees can view it on www.pmi.com/2021barclays. Presentation slides will also be available. An archived version of the webcast will be accessible until October 7, 2021, at 5:00 p.m. ET.
PMI is focused on transitioning to a smoke-free future, making strides in smoke-free product innovation.
Philip Morris International (PMI) has announced a new business transformation-linked financing framework to support its smoke-free initiatives. The framework aims to align PMI's financing strategy with its sustainability goals, reinforcing its commitment to phasing out cigarettes. Key Performance Indicators (KPIs) include increasing the smoke-free revenue percentage to over 50% by 2025 and expanding the number of markets for smoke-free products to 100. The framework has been validated by S&P Global Ratings, highlighting its ambitious and measurable targets for a smoke-free future.
Philip Morris International (PM) has launched IQOS ILUMA, a new tobacco-heating device that utilizes innovative induction-heating technology, marking a significant advancement in their smoke-free product portfolio. This launch follows PMI's commitment to replace cigarettes with better alternatives, with over 20 million global users of the IQOS system. IQOS ILUMA offers cleaner operation with no blades or cleaning required, and emits 95% lower levels of harmful chemicals. Available for pre-order in Japan from August 17, 2021, it represents PMI's ambition to expand its smoke-free product reach to 100 markets by 2025.
Philip Morris International (PMI) has published an offer document to acquire Vectura Group plc for 165 pence per share, representing a 60% premium over the last closing price. This acquisition aligns with PMI's strategy to transform into a smoke-free company and develop inhaled therapeutic products. PMI aims for $1 billion in annual revenues from Beyond Nicotine sources by 2025, having already invested $8.1 billion since 2008 in smoke-free innovations. The deal, valued around 15 times Vectura's 2020 EBITDA, is expected to close in the second half of 2021, pending shareholder acceptance and regulatory approvals.
FAQ
What is the current stock price of Philip Morris (PM)?
What is the market cap of Philip Morris (PM)?
